Waldman Lawrence bought APYX

June 30, 2026 · Form 4 insider transaction

Waldman Lawrence bought 12,000 shares of Apyx Medical Corporation at $1.88 per share, a transaction worth $22.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
12,000
Price
$1.88
Total value
$22.6K
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 30, 2026
Filing dateJuly 2, 2026
Shares owned after17,338
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any.

View the original Form 4 on SEC EDGAR